COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry.

peer reviewed ; In a cohort of severe asthma patients, a small number of COVID-19 cases was found; none resulted in death or a very severe disease course. Use of biologics for severe allergic or severe eosinophilic asthma was not associated with a higher risk of COVID-19. https://bit.ly/3ndZmyD

Verfasser: Hanon, Shane
Brusselle, Guy
Deschampheleire, Maud
Louis, Renaud
Michils, Alain
Peché, Rudi
Pilette, Charles
Rummens, Peter
Schuermans, Daniel
Simonis, Hélène
Vandenplas, Olivier
Schleich, Florence
Dokumenttyp: journal article
Erscheinungsdatum: 2020
Verlag/Hrsg.: European Respiratory Society
Schlagwörter: Human health sciences / Cardiovascular & respiratory systems / Sciences de la santé humaine / Systèmes cardiovasculaire & respiratoire
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-28889162
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://orbi.uliege.be/handle/2268/257087